The Dawn of BE READY: Europe's Bold Step in Pandemic Defense
The European Commission has officially unveiled the BE READY European Partnership, a landmark initiative injecting €240 million over the next decade into research aimed at fortifying the continent against future pandemics. Launched on February 17, 2026, in Paris by the Commission alongside France's ANRS Emerging Infectious Diseases agency, this collaboration unites 81 organizations across 27 countries to pioneer advancements in detecting, treating, and preventing outbreaks from emerging and re-emerging pathogens.
At its core, BE READY addresses the sobering lessons from COVID-19, mpox, and ongoing threats like avian influenza H5N1. By harmonizing national research efforts under the Horizon Europe framework, the partnership promises faster deployment of diagnostics, therapeutics, and vaccines when crises strike. European Commissioners Hadja Lahbib and Ekaterina Zaharieva hailed it as a 'bold step forward' and a commitment to 'sound scientific foundations,' underscoring Europe's resolve to place research at the forefront of health security.
This initiative not only bolsters public health but also opens new avenues for higher education institutions, positioning universities as pivotal hubs for interdisciplinary innovation.
From COVID Chaos to Strategic Preparedness: The Imperative Behind BE READY
The COVID-19 pandemic exposed critical vulnerabilities in Europe's response mechanisms, from supply chain disruptions for personal protective equipment to delays in vaccine rollout. Since 2020, the EU has channeled over €1.8 billion into pandemic-related research via its framework programs, yet gaps persist in coordinated, 'ever-warm' systems ready for immediate activation.
BE READY evolves from predecessor projects like BE READY NOW (a Horizon Europe co-funded action launched in 2023) and BE READY PLUS, which laid the groundwork by developing a Strategic Research and Innovation Agenda (SRIA). These efforts highlighted the need for a unified ecosystem integrating surveillance, basic research, and rapid clinical trials. Today, with climate change amplifying zoonotic spillovers and antimicrobial resistance on the rise, the partnership arrives at a pivotal moment.
Statistics paint a stark picture: The World Health Organization estimates that pandemics could cost the global economy trillions annually, while Europe's 2020-2022 losses exceeded €1 trillion. Universities, with their expertise in virology, epidemiology, and bioinformatics, are uniquely equipped to bridge these gaps through sustained, collaborative inquiry.
Unpacking the BE READY Framework: Structure, Governance, and Ambitions
Coordinated by ANRS-MIE, BE READY operates as a Horizon Europe Partnership, blending €120 million in EU funds with matching national contributions for a total €240 million commitment spanning 10 years. Its governance revolves around three pillars: building the partnership, crafting the SRIA, and forging synergies with entities like the Health Emergency Preparedness and Response Authority (HERA), European Centre for Disease Prevention and Control (ECDC), and European Medicines Agency (EMA).
The SRIA outlines priorities across basic research on pathogen biology, platform technologies for diagnostics and countermeasures, and public health interventions. Joint Transnational Calls (JTCs)—such as the ongoing JTC 2026—enable researchers from multiple countries to secure coordinated funding, ensuring projects scale efficiently.
This structure fosters an 'ever-warm' ecosystem: Networks of clinical trial sites stand ready, data platforms enable real-time sharing, and interdisciplinary teams tackle threats holistically.
Universities at the Helm: Academic Powerhouses Driving BE READY
Higher education institutions form the backbone of BE READY's research engine. From the predecessor BE READY NOW project alone, prominent universities include University College London and the University of Oxford (UK), Karolinska Institutet and Uppsala Universitet (Sweden), Università degli Studi di Verona (Italy), Charité – Universitätsmedizin Berlin (Germany), and Medizinische Universität Wien (Austria).
Other key academic players: Université Libre de Bruxelles and Universiteit Antwerpen (Belgium), University College Dublin and University of Galway (Ireland), Université du Luxembourg, and Poland's Uniwersytet Medyczny w Białymstoku. These institutions contribute expertise in clinical networks, pathogen surveillance, and vaccine development.Explore research positions in these consortia via platforms like AcademicJobs.com higher ed jobs.
- University College London (UCL): Leads in infectious disease modeling and rapid diagnostics.
- University of Oxford: Pioneers mRNA vaccine platforms, building on COVID successes.
- Karolinska Institutet: Focuses on immunology and therapeutic countermeasures.
- Charité Berlin: Hosts EU-wide clinical trial hubs for emerging threats.
For European academics, involvement means access to cutting-edge labs, international collaborations, and funding streams that enhance career trajectories.
Core Research Pillars: Targeting Pathogens, Platforms, and People
BE READY's SRIA divides efforts into actionable domains. First, deepening understanding of pathogen-host interactions for viruses like Nipah, henipaviruses, and filoviruses with pandemic potential. Second, developing modular platforms for diagnostics (e.g., point-of-care tests) and countermeasures (vaccines deployable in 100 days).
Third, bolstering public health: Surveillance systems, behavioral interventions, and equitable access strategies. The One Health paradigm integrates human, animal, and environmental factors, exemplified by monitoring zoonotic hotspots.Visit the official BE READY site for SRIA details.
Real-world application: Drawing from COVID, where Europe's vaccine rollout lagged initially, BE READY prioritizes 'plug-and-play' technologies adaptable to novel threats.
Photo by Jakub Żerdzicki on Unsplash
Funding the Future: Joint Calls and Opportunities for Innovators
The flagship mechanism is JTCs, where national funders pool resources for multinational projects. The 2026 call, 'Advancing Knowledge of Host-Pathogen Interactions,' invites proposals on transmission dynamics and immune responses, requiring at least three partners from different countries.
- Eligibility: Universities, institutes, SMEs from 27+ participating nations.
- Process: Pre-proposal submission, full proposals, peer review, national checks.
- Budget per project: Up to €2-5M, multi-year.
Early career researchers can lead via university teams, fostering mentorship and publication pipelines. Check scholarships and research jobs for aligned opportunities.
Download JTC 2026 call text.One Health in Action: Holistic Defense Against Zoonotic Threats
BE READY champions One Health—Full name: One Health Approach (OHA), an integrated framework recognizing interconnections between human, animal, and environmental health. Step-by-step: (1) Surveillance in wildlife reservoirs, (2) Genomic sequencing for early detection, (3) Modeling spillover risks, (4) Cross-sector interventions.
Example: Partnering with ECDC on bat virome monitoring, universities like Oxford deploy field teams in high-risk areas. This prevents events like the 2022 mpox outbreak from escalating globally.
Cultural context: In diverse Europe, equitable strategies address migration-driven risks, benefiting universities in border regions.
Higher Education Transformation: Careers, Training, and Innovation Hubs
BE READY elevates universities as innovation epicenters. Expect surges in PhD/postdoc positions in virology, epidemiology, and data science. Institutions like Karolinska are scaling training programs, integrating AI for outbreak prediction.
Stakeholder views: Prof. Yazdan Yazdanpanah (ANRS) emphasizes 'university-led agility.' Impacts: Enhanced rankings via high-impact publications, attracting global talent. For faculty, craft a standout CV targeting these calls.
Actionable insight: Join networks via Rate My Professor for collaborations.
Proven Precedents: Successes Paving BE READY's Path
BE READY NOW funded 20+ projects, yielding rapid diagnostics for mpox and avian flu models. University of Verona's consortium trialed next-gen antivirals, reducing development time by 30%. Uppsala's zoonotic surveillance platform now informs ECDC alerts.
Timeline: 2022-2025 preps → 2026 launch → First JTC results by 2028. These cases demonstrate ROI: €1 invested yields €7 in health savings.
BE READY NOW on CORDIS.Navigating Challenges: Equity, Ethics, and Global Alignment
Challenges include funding disparities across nations and ethical AI use in surveillance. Solutions: BE READY mandates diverse consortia, ethics reviews, and LMIC partnerships. Expert opinion: UCL's Prof. Wendy Barclay notes, 'Balanced views prevent silos.'
Photo by Dimitri Karastelev on Unsplash
- Risks: Data privacy in pan-EU platforms.
- Solutions: GDPR-compliant federated learning.
- Comparisons: Stronger than US BARDA, more collaborative than WHO hubs.
Future Horizons: BE READY's Long-Term Legacy
By 2035, anticipate routine 100-day vaccine platforms and AI-driven early warnings. For higher ed, this means specialized degrees in pandemic science, boosting employability. Outlook: Aligns with EU's €5.3B Health Cluster, positioning Europe as global leader.
Actionable: Monitor postdoc openings, apply to JTCs. Engage via university international offices.
In summary, BE READY isn't just funding—it's a career catalyst. Explore higher ed jobs, rate professors, and career advice to join the vanguard. University jobs in research await.
